✦ LIBER ✦

Daclizumab + tacrolimus a feasible corticosteroid-free regimen

Book ID: 120854832
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200514800-00028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corticosteroid-free regimen feasible aft

Corticosteroid-free regimen feasible after renal transplantation

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Corticosteroid-free immunosuppression wi

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: A large randomized clinical study

✍ Olivier Boillot; David A. Mayer; Karim Boudjema; Mauro Salizzoni; Bruno Gridelli 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

This open, randomized (1 : 1), multicenter, 3-month study compared a dual tacrolimus plus steroids (Tac / steroids) regimen with a steroid-free immunosuppressive regimen of tacrolimus following daclizumab induction therapy (Tac / Dac) in adult liver transplant recipients. The full analysis set compr

Steroid-free regimen with daclizumab, my

Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients

✍ J Figueras; A Bernardos; M Prieto; M Gómez; A Rimola; J Ortiz de Urbina; V Cuerv 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Two-Dose Daclizumab, Tacrolimus, Mycophe

Two-Dose Daclizumab, Tacrolimus, Mycophenolate Mofetil, and Steroid-Free Regimen in De Novo Cardiac Transplant Recipients: Early Experience

✍ S. Mastrobuoni; M. Ubilla; A. Cordero; J. Herreros; G. Rabago 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Tacrolimus combined with two different c

Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results

✍ Bernhard K. Krämer; Marian Klinger; Zbigniew Wlodarczyk; Marek Ostrowski; Karste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n